Compare STE & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STE | BNTX |
|---|---|---|
| Founded | 1985 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 24.8B |
| IPO Year | 1992 | 2019 |
| Metric | STE | BNTX |
|---|---|---|
| Price | $263.47 | $96.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $268.25 | $137.40 |
| AVG Volume (30 Days) | 653.3K | ★ 1.3M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 59.39 | N/A |
| EPS | ★ 6.97 | N/A |
| Revenue | ★ $5,702,415,000.00 | $3,698,814,972.00 |
| Revenue This Year | $9.24 | $2.36 |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | $37.76 | ★ N/A |
| Revenue Growth | ★ 7.08 | 3.70 |
| 52 Week Low | $200.98 | $81.20 |
| 52 Week High | $268.60 | $129.27 |
| Indicator | STE | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 39.97 |
| Support Level | $256.68 | $95.61 |
| Resistance Level | $268.60 | $98.20 |
| Average True Range (ATR) | 4.64 | 2.93 |
| MACD | -0.69 | -0.51 |
| Stochastic Oscillator | 65.59 | 22.39 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.